Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $39.
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $39.